{"schema_version":"secwatch.filing_event.v1","accession":"0001438133-22-000106","form_type":"8-K","ticker":"TNDM","cik":"0001438133","company_name":"TANDEM DIABETES CARE INC","filed_at":"2022-05-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.721031+00:00","generated_at":"2026-06-25T06:15:58.162613+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Tandem Diabetes shareholders elect directors, approve board declassification and say-on-pay","bullets":["Peyton R. Howell and John F. Sheridan elected as Class III directors with ~98.6% and ~98.1% of votes cast.","Amendment to declassify board (annual elections) approved with 99.9% of votes cast in favor.","Non-binding advisory vote on named executive officer compensation approved with ~98.4% of votes cast.","Ratification of Ernst & Young as independent auditor for FY2022 approved with ~97.7% of votes cast."],"urls":{"canonical":"https://secwatch.observer/filing/0001438133-22-000106","json":"https://secwatch.observer/filing/0001438133-22-000106.json","markdown":"https://secwatch.observer/filing/0001438133-22-000106.md","text":"https://secwatch.observer/filing/0001438133-22-000106.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1438133/000143813322000106/0001438133-22-000106-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1438133/000143813322000106/tndm-20220525.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T06:15:58.162613+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}